anticoagulant/blæðing

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

Bls 1 frá 823 niðurstöður

Suloexide in the Treatment of Early Stages of COVID-19

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Objective: To use sulodexide in patients that have early onset of COVID-19 symptoms to mitigate the progression of the disease process that can allow them to recover at home, and limit the need for hospital care and the more severe manifestation which includes fulminant respiratory failure, acute

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The combination of aspirin plus a P2Y12 receptor inhibitor, also known as dual antiplatelet therapy (DAPT), is the cornerstone of treatment for patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). However, a considerable number of patients undergoing PCI

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

All guidelines have embraced the concept of extended DVT prophylaxis after major abdominal or pelvic surgery for cancer, but the recommendation is consistently to use LMWH, which is more complicated than orally available prophylaxis, more expensive and has poor adherence. The patients will be

Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The 2017 guideline gives a class IIA recommendation ('should be considered') for complete revascularisation in patients presenting with STEMI and multivessel disease, which is approximately 50% of the STEMI population. Staged multivessel PCI during hospitalization (3-5 days after PPCI) is common in

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Patients will be treated as standard of care, no randomization schedule, no blinded investigational product (IP). The decision which DOAC will be given is made before the subject will enter the trial. The DOAC has to be taken at least for seven days. The registry is non-interventional (NIS) with

Feasibility and Prognosis of Left Atrial Appendage Closure in Patients With Heart Failure and Atrial Fibrillation

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Patients selection All patients underwent left atrial appendage closure in Assiut university in the period from January 2014 to December 2019 will be included. Inclusion criteria In this retrospective cohort study, atrial fibrillation patients with previous major bleeding, bleeding predisposition or

Study on Inferior Vena Cava Thrombosis

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Thrombosis of the inferior vena cava (IVC) is a rare form of deep venous thrombosis (DVT). Optimal treatment strategies and clinical outcomes are not well established. This multicenter, international, observational study will assess the effectiveness and safety of current treatment options in

Biomarkers of CASH

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Cerebral cavernous angioma (CA) is a capillary microangiopathy affecting more than a million Americans, predisposing them to a premature risk of brain hemorrhage. Fewer than 200,000 cases who have suffered a recent symptomatic hemorrhage (SH) are most likely to re-bleed again with serious clinical

Hesperidin and Diosmin for Treatment of COVID-19

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Research Background and Rationale At the end of December 2019, pneumonia of unknown origin was detected in the hospitals of Wuhan city, China, and reported to the WHO country office for the first time [1-3]. After a few days, the Chinese government has confirmed the human-to-human transmission of

Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Northeast COVID-19 and Pregnancy Study Group

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

General Objective: To determine the frequency of COVID-19 in pregnant and postpartum women admitted with flu syndrome, to evaluate the clinical and laboratory predictors of COVID-19 progression and to identify the factors associated with adverse maternal and perinatal / neonatal outcomes in six

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

This study is a prospective randomized study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is atrial fibrillation patients with moderate or high stroke risk (CHA2DS2-VASc>=1 male, and >=2 female) who had undergone catheter ablation of atrial fibrillation, and has

Fyrri
1
2
3
4
5
6
...
54
55
Næst

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum